Skip to main content

 

The Center has established three research facilities:

  1. The Translational Nanoformulation Laboratory: This lab facilitates the translation of new drug candidates into clinical trials through advanced formulation techniques. Its mission is to develop innovative nanotechnologies for the delivery of therapeutic and diagnostic agents. The TransNanoForm Lab specializes in working with Lipid Nanoparticles (LNPs), exosomes, micelles, nanocrystals, nanosuspensions, and liposomes.
  2. The Nanomedicines Characterization Core Facility: This facility accelerates the clinical translation of new nanomedicines by providing comprehensive physicochemical characterization. It also offers training on various techniques, including chemical composition, molar mass (Mn and Mw), polydispersity, molecular weight distribution, size, shape, surface charge, solubility, thermal/oxidative stabilities, isotope analysis, UV/VIS spectroscopy, and more. The Core personnel offer expert opinions related to study design, sample selection/collection and storage, proposal review and development, and manuscript development and review.
  3. The Quantitative Targeted Proteomics Core Facility: This facility specializes in the quantification of proteins in biological matrices using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). LC-MS/MS allows for highly sensitive and specific quantification and identification of molecules, making it a powerful tool in proteomics, drug development, and various fields of biochemical research.

Research Facilities

  1. Translational Nanoformulation Core Facility (TransNanoForm)
  2. Nanomedicines Characterization Core Facility (NCore)
  3. The Quantitative Targeted Proteomics Core Facility (QTAP) Core.